Skip to main content

Clinical Laboratory Medicine and Transgender Health

From the 2022 Joint Annual Meeting (recorded 6/29/2022)
Presented by Carlo Ledesma, MS, MLS(ASCP)CM,SHCM, QLSCM, DLMCM, MT(AMT)

Clinical decisions contributing to positive patient outcomes are guided, in part, by clinical laboratory results. However, ambiguity and lack of consensus in standardizing laboratory results for transgender patients are significantly missing in clinical laboratory medicine. This session will outline current scientific evidence and standards of care in relation to transgender health and discuss the role of clinical laboratories in promoting positive patient outcomes for transgender patients and those who are in gender-affirming therapies.

LEARNING OBJECTIVES
At the conclusion of this presentation, participants will be able to:

  • Discuss the role of clinical laboratories in transgender health
  • Discuss the impact of endocrinologic management in common laboratory tests
  • Discuss evidence-based recommendations in the care of transgender patients.

CE ACCREDITATION
ASCLS is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. One (1) P.A.C.E. ® contact hour and one (1) Florida credit hour in the area of GEN (General) will be awarded to participants. ASCLS P.A.C.E.® is accepted by the ASCP/ASCLS/AGT Board of Certification and all states, including Florida and California, as an approved provider of continuing education for recertification and licensure. ASCLS is an approved provider with CE Broker for Florida licensees.


LEVEL OF INSTRUCTION
This Intermediate-level program is appropriate for laboratory professionals working in clinical, public health and academic settings.